This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BONE_CARTILAGE_NAS_EXALLC for full statistics.
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
C3_BONE_CARTILAGE_NAS
bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
164 |
4. Check minimum number of eventsNone |
164 |
5. Include endpointsNone |
164 |
6. Filter based on genotype QC (FinnGen only) |
164 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of bone and articular cartilage
- Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 164 | 76 | 88 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 58.01 | 55.37 | 60.28 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 155
- Matched controls
- 1548
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
133.6
38.8
40
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
21.9
32.2
48
31
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
192.0
30.9
31
*
C90.0
ICD-10 Finland
Multiple myeloma
48.2
23.6
28
7
H02AB02
ATC
dexamethasone; systemic
8.9
23.5
55
90
XW000
NOMESCO Finland
Bone marrow biopsy
17.6
22.7
36
26
L03AA02
ATC
filgrastim; parenteral
23.3
22.4
32
17
JN4BD
NOMESCO Finland
Extensive body CT
7.6
21.7
57
110
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
227.8
20.0
20
*
N02AA05
ATC
oxycodone; systemic
6.6
20.0
59
132
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.0
19.9
95
371
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
31.2
18.5
24
9
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
189.4
16.8
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.4
16.2
46
95
130
Kela drug reimbursment
Malignant tumour
7.7
15.9
39
65
WF049
NOMESCO Finland
Radiotherapy of metastasis
14.6
15.6
26
21
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.9
15.0
29
32
9220/3-C41.3
ICD-O-3
Chondrosarcoma, NOS, of rib, sternum, clavicle and associated joints
+∞
14.8
14
*
C41.49
ICD-10 Finland
Malignant tumor of the pelvic bones, sacrum and coccyx other or unspecified histology
+∞
14.8
14
*
N03AX16
ATC
pregabalin; oral
4.3
14.0
64
219
WW300
NOMESCO Finland
Transfer of autologic stem cells
54.9
13.1
15
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
13.0
53
161
JN4AD
NOMESCO Finland
Body CT examination
6.1
12.9
37
76
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
76.2
12.8
14
*
9370/3-C41.4
ICD-O-3
Chordoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
12.7
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.0
12.5
59
205
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
23.6
12.3
17
8
A04AA01
ATC
ondansetron; systemic, rectal
6.9
12.2
31
54
R4110
NOMESCO Finland
Physiotherapy
3.7
11.9
65
253
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
70.4
11.8
13
*
C41.32
ICD-10 Finland
Chondrosarcoma of the ribs, sternum and clavicle
+∞
11.6
11
*
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
11.6
11
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
11.5
31
58
153
Kela drug reimbursment
Lenalidomid
38.1
11.5
14
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
22.1
11.4
16
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
11.2
98
532
NE1AA
NOMESCO Finland
Pelvis X-ray examination
6.4
11.2
30
56
L04AX04
ATC
lenalidomide; oral
64.5
10.8
12
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
117.6
10.6
11
*
C41.40
ICD-10 Finland
Pelvic bones, sacrum and coccyx
+∞
10.5
10
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.0
10.3
23
33
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.7
10.2
26
45
L03AA13
ATC
pegfilgrastim; parenteral
9.8
10.1
20
23
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.4
10.1
31
68
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
18.3
10.1
15
9
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
12.6
9.8
17
15
B01AB05
ATC
enoxaparin; parenteral
3.1
9.8
71
331
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
58.7
9.8
11
*
AA1AA
NOMESCO Finland
Head X-ray examination
32.2
9.5
12
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.7
9.5
20
26
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
9.5
9
*
9220/3-C41.4
ICD-O-3
Chondrosarcoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
9.5
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
9.4
67
307
A04AA02
ATC
granisetron; systemic, transdermal
5.7
9.0
26
53
329
Kela drug reimbursment
Lenalidomide
53.0
8.8
10
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
11.0
8.8
16
16
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.5
8.8
26
55
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
21.5
8.6
12
6
WF002
NOMESCO Finland
Radical radiotherapy
5.7
8.5
24
48
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
8.4
8
*
WW500
NOMESCO Finland
Blood transfusion
7.6
8.4
19
28
WZC30
NOMESCO Finland
Teaching
3.7
8.3
39
130
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
8.1
35
109
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
14.0
8.0
13
10
J05AB01
ATC
aciclovir; systemic
3.2
7.9
46
180
ZX120
NOMESCO Finland
Intravenous
4.3
7.7
29
79
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.5
7.6
22
45
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.4
7.5
22
46
C41.41
ICD-10 Finland
Osteosarcoma of the pelvic bones, sacrum and coccyx
+∞
7.3
7
*
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
+∞
7.3
7
*
C41.3
ICD-10 Finland
Malignant neoplasm: Ribs, sternum and clavicle
+∞
7.3
7
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
7.3
7
*
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
+∞
7.3
7
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
7.3
7
*
C41.22
ICD-10 Finland
Chondrosarcoma of the spine
+∞
7.3
7
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.7
7.2
20
39
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
21.2
7.2
10
5
JN4CD
NOMESCO Finland
Very extensive body CT
5.6
7.1
20
40
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
14.7
7.0
11
8
R50.9
ICD-10 Finland
Fever, unspecified
3.2
6.9
38
141
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
11.7
6.9
12
11
WX402
NOMESCO Finland
General anaesthesia
3.1
6.9
41
161
Z51.5
ICD-10 Finland
Palliative care
5.0
6.8
21
47
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.0
6.8
21
47
WF004
NOMESCO Finland
Palliative radiotherapy
10.7
6.7
12
12
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
15.1
6.5
10
7
B01AB10
ATC
tinzaparin; parenteral
4.7
6.4
21
50
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
27.9
6.3
8
*
9220/3-C41.0
ICD-O-3
Chondrosarcoma, NOS, of bones of skull and face and associated joints
+∞
6.3
6
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.2
6.2
14
21
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
6.1
37
146
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
6.3
6.0
15
26
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40760888) Immunoglobulin light chains.free panel - Serum
40
40
12.90
36.90
11.7
4.9
—
—
—
0
0
(4035726)
64
132
7.31
32.57
1.6
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
42
55
9.92
31.75
12.7
4.1
mg/l
43.8
32.2
0.17
36
41
(3034860) Kappa light chains.free [Mass/volume] in Serum
42
55
9.92
31.75
12.8
4.1
mg/l
34.7
167.0
0.54
36
41
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
67
159
6.43
29.23
8.0
4.6
u/l
226.9
251.2
1.01
67
152
(21494890) Protein electrophoresis panel - 24 hour Urine
28
23
14.47
28.87
3.5
2.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
28
35
9.44
21.58
4.6
2.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
47
110
5.59
20.11
11.0
3.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
64
197
4.69
19.69
6.7
7.0
mmol/l
1.0
1.0
0.01
64
183
(3047189) Immunofixation for 24 hour Urine
18
13
15.43
19.66
2.3
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
44
113
4.95
16.69
6.7
3.0
g/l
9.6
10.4
0.56
44
103
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
16
10.97
14.25
1.2
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
121
683
3.94
14.25
10.2
6.3
e9/l
0.6
0.6
0.25
112
596
(3019198) Lymphocytes [#/volume] in Blood
122
697
3.93
14.00
10.3
6.4
e9/l
1.5
1.8
2.94
113
623
(3012095) Magnesium [Moles/volume] in Serum or Plasma
65
250
3.65
13.99
5.5
4.5
mmol/l
0.8
0.8
0.14
65
236
(3023368) Bacteria identified in Blood by Culture
87
403
3.47
13.95
7.3
4.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
122
701
3.89
13.78
10.6
6.6
e9/l
0.2
0.2
0.15
113
626
(3006315) Basophils [#/volume] in Blood
120
684
3.81
13.69
10.3
6.3
e9/l
0.0
0.0
1.66
110
598
(3013650) Neutrophils [#/volume] in Blood by Automated count
131
811
4.06
12.72
22.7
10.7
e9/l
3.7
4.0
1.07
123
707
(42870588) Differential panel, method unspecified - Blood
90
457
3.15
11.86
8.7
6.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
75
343
3.19
11.86
4.0
2.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
94
4.30
11.51
6.1
4.2
%
1.1
0.2
—
10
21
(3017143) Hepatitis C virus Ab [Presence] in Serum
48
170
3.58
11.45
1.5
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
115
689
3.24
11.05
18.1
7.4
mmol/l
1.2
1.2
1.63
100
581
(3042936) Bacteria identified in Isolate by Culture
56
224
3.28
10.97
2.5
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
86
448
2.93
10.47
4.7
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
46
168
3.42
10.38
9.2
9.0
mmol/l
1.8
1.2
0.44
34
138
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
109
650
3.02
10.25
6.5
4.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
40
5.56
9.85
1.9
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
29
6.42
9.81
1.8
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
33
6.00
9.68
1.8
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
117
3.66
9.66
1.3
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
32
96
3.90
9.63
7.2
4.4
%
0.5
0.1
—
10
27
(3032080) INR in Blood by Coagulation assay
100
582
2.84
9.62
11.6
9.1
inr
1.3
1.2
0.08
30
164
(3017181) Myelocytes/100 leukocytes in Blood
34
107
3.75
9.55
6.9
4.2
%
1.9
1.0
0.63
11
33
(3011412) CD3 cells [#/volume] in Blood
14
20
7.56
9.44
2.1
2.3
e9/l
1.1
1.3
—
9
10
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
17
8.22
9.41
3.3
3.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
65
4.36
9.08
9.0
2.5
g/l
7.7
7.8
0.10
16
52
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
65
4.36
9.08
9.0
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
65
4.36
9.08
9.0
2.5
g/l
3.6
3.8
0.29
13
47
(40768804) Tissue Pathology biopsy report
95
550
2.73
9.05
3.3
2.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
15
8.55
8.98
1.2
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
195
3.07
8.96
1.5
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
42
159
3.21
8.83
1.6
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
23
59
4.37
8.48
9.0
2.6
g/l
0.6
0.9
0.21
18
53
(3023520) Reticulocytes [#/volume] in Blood
36
127
3.35
8.46
2.7
3.0
e9/l
72.5
69.3
0.21
30
100
(3025159) Blasts/100 leukocytes in Blood
30
94
3.68
8.44
7.4
4.5
%
0.0
0.3
—
10
23
(3026493) Urate [Moles/volume] in Serum or Plasma
69
356
2.62
8.08
4.7
3.1
umol/l
7726.5
7936.7
0.01
64
299
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
46
4.54
7.50
2.3
3.8
u/ml
0.3
0.3
0.08
11
24
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
16
7.30
7.24
2.0
2.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
17
6.86
6.87
1.1
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
60
3.87
6.69
11.0
2.6
g/l
9.0
10.3
0.92
16
51
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
62
3.74
6.39
10.2
2.5
g/l
3.2
3.2
0.03
13
48
(3042631) Mycobacterium sp identified in Specimen
10
16
6.59
6.03
2.2
3.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
16
6.59
6.03
1.4
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
15
36
4.49
5.96
1.9
1.5
u/l
11.4
7.6
—
10
29
(3017704) Immunofixation for Urine
10
9
11.73
5.88
3.0
2.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
13
28
4.96
5.84
1.9
1.8
e6/l
152.6
112.3
0.10
13
19
(3002256) Pathology report gross observation
37
165
2.60
5.61
1.2
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
47
240
2.34
5.31
2.4
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
35
4.28
5.29
1.7
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
27
106
2.85
5.20
8.3
8.6
mmol/l
25.3
24.8
0.31
27
106
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
83
537
2.10
5.18
4.2
3.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
6
13.92
5.13
1.9
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
45
231
2.31
5.00
1.7
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
83
546
2.05
4.87
4.2
3.8
ng/l
30.7
49.8
0.94
70
401
(40758558) Short blood count panel - Blood
60
353
2.10
4.73
21.3
7.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
51
283
2.16
4.66
3.4
1.5
g/l
2.5
2.5
0.03
42
165
(3044290) Cell count panel - Cerebral spinal fluid
11
25
4.64
4.64
1.9
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
21
5.01
4.59
1.3
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
21
5.01
4.59
1.1
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
52
295
2.12
4.47
9.3
6.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
72
3.02
4.47
3.0
3.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
88
604
1.99
4.46
20.6
11.1
e9/l
0.0
0.0
0.54
73
490
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
6
12.11
4.31
2.1
2.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
46
3.49
4.30
1.7
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
52
300
2.07
4.25
3.2
2.9
e6/l
4.2
4.3
0.01
46
264
(3018418) pH of Serum or Plasma
67
426
1.97
4.17
11.8
4.6
ph
7.4
7.4
0.62
21
87
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
10
8.34
4.11
2.1
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
48
3.34
4.04
1.7
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
83
2.75
3.98
10.9
10.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
64
407
1.94
3.94
3.7
3.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
11
7.58
3.90
1.0
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
28
130
2.39
3.85
13.9
10.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
8
9.07
3.81
2.1
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
66
428
1.91
3.81
3.7
3.3
e6/l
1.2
0.3
0.39
51
313
(3048879) Bone marrow aspiration report
6
5
12.38
3.79
2.0
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
99
2.54
3.70
4.4
4.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
14
46
3.23
3.62
3.1
3.4
kpa
8.3
8.7
0.34
14
39
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
141
2.28
3.59
5.2
3.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
41
3.36
3.58
2.6
2.5
mmol/l
27.6
23.7
1.85
13
32
(3002582) Erythrocytes [#/volume] in Urine
69
465
1.84
3.46
4.5
3.4
e6/l
26.8
172.2
0.53
58
354
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
109
2.41
3.46
2.7
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
55
345
1.89
3.46
2.2
2.0
mg/l
2.6
3.0
0.81
47
301
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
31
158
2.19
3.43
5.9
4.9
ug/l
5.1
36.0
0.60
25
131
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
32
3.61
3.40
1.5
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
153
1347
3.03
3.38
37.3
15.3
mg/l
29.8
25.1
1.08
140
1078
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
14
5.94
3.38
1.4
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
14
5.94
3.38
1.3
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
22
98
2.44
3.30
3.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
56
358
1.86
3.30
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
113
2.32
3.19
3.1
3.0
ml/min/173m2
69.3
63.8
0.29
12
52
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
50
2.97
3.17
2.6
1.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
12
6.04
3.05
2.1
3.8
u/ml
18.6
21.7
—
7
12
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
47
296
1.82
2.86
4.1
2.0
mg/l
0.9
1.3
1.49
38
235
(3026008) Bacteria identified in Urine by Culture
61
417
1.74
2.81
4.4
2.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
48
2.86
2.79
2.2
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
14
5.17
2.76
3.0
1.3
pg
31.1
32.7
—
7
14
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
23
114
2.18
2.72
13.3
5.2
mmol/l
1.2
1.2
0.96
23
105
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
32
3.26
2.69
1.9
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
32
3.26
2.69
1.9
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
33
3.16
2.57
1.2
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
132
1131
1.86
2.54
40.6
18.9
%
14.2
13.7
3.17
127
1116
(3044889) 12 lead EKG panel
115
950
1.70
2.49
4.2
4.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
27
3.47
2.43
2.4
2.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
27
3.47
2.43
1.7
1.7
—
—
—
0
0
(3012544) pH of Venous blood
27
149
1.97
2.43
5.9
4.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
17
4.25
2.38
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
28
3.34
2.34
7.7
4.7
%
60.9
59.4
—
9
28
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
28
3.34
2.34
6.0
4.1
e9/l
3.7
4.9
—
9
28
(3018095) Leukocytes [#/volume] in Urine
70
517
1.62
2.32
5.7
4.0
e6/l
88.5
69.5
0.16
59
369
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
24
129
2.01
2.32
1.8
2.6
g/l
0.2
0.2
0.28
24
119
(3024354) Oxygen [Partial pressure] in Venous blood
23
122
2.03
2.30
3.7
4.2
kpa
4.1
4.7
1.64
23
115
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
80
2.26
2.28
2.4
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
18
4.01
2.28
3.3
4.1
—
—
—
0
0
(3019225) pH of Specimen
24
130
1.99
2.27
9.5
4.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
26
145
1.94
2.27
6.1
4.8
kpa
6.0
5.7
0.45
26
138
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
29
3.22
2.26
1.7
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
143
1274
1.96
2.20
32.7
14.0
ml/min/173m2
80.9
80.1
0.13
126
1046
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
178
1.84
2.18
2.4
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
40
262
1.70
2.08
2.9
2.8
e6/l
0.5
1.1
1.32
24
149
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
20
3.61
2.08
1.3
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
173
1.82
2.07
2.4
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
34
213
1.75
2.07
4.0
2.4
g/l
2.2
2.3
0.50
34
193
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
38
249
1.68
1.97
4.1
3.0
e6/l
3.6
1.9
0.42
24
137
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
33
2.83
1.96
1.7
1.8
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
8
27
3.06
1.96
2.8
2.3
mmol/l
1.9
1.6
—
8
27
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
39
2.67
1.96
1.5
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
39
2.67
1.96
1.6
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
119
1020
1.61
1.95
6.8
4.3
mm/h
18.7
12.4
2.25
119
937
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
11
4.65
1.95
5.2
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
112
947
1.58
1.95
5.7
4.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
46
2.49
1.89
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
47
2.44
1.82
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
47
2.44
1.82
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
81
2.08
1.82
1.4
1.3
—
—
—
0
0
(3013512) EKG study
56
413
1.54
1.79
5.5
4.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
18
3.42
1.76
3.2
3.4
nmol/l
4.0
4.4
—
6
18
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
18
3.42
1.76
1.3
1.7
—
—
—
0
0
(44806118)
7
24
3.00
1.74
1.6
1.7
—
—
—
0
0
(44790048)
7
24
3.00
1.74
1.6
1.7
—
—
—
0
0
(44790047)
7
24
3.00
1.74
1.6
1.7
—
—
—
0
0
(44790049)
7
24
3.00
1.74
1.6
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
13
3.93
1.73
1.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
49
2.33
1.67
2.5
2.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
14
3.65
1.62
2.0
2.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
14
3.65
1.62
1.4
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
20
3.07
1.59
1.5
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
33
2.50
1.56
1.6
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
15
3.40
1.53
1.4
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.40
1.53
1.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
15
3.40
1.53
1.8
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.40
1.53
1.8
1.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
154
1441
2.13
1.53
42.2
17.9
umol/l
85.7
78.9
0.67
154
1441
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
73
2.00
1.49
1.3
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
38
267
1.55
1.49
1.7
1.7
nmol/l
1437.9
1188.3
0.56
30
200
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
28
2.56
1.47
2.1
4.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
39
2.38
1.45
1.6
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
16
3.19
1.45
2.0
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
69
551
1.44
1.44
1.9
2.0
pmol/l
86.5
93.8
0.50
43
276
(3005322) IgE [Units/volume] in Serum or Plasma
14
74
1.98
1.44
1.2
1.2
u/ml
1078.7
181.6
0.44
14
66
(3020891) Body temperature
11
53
2.15
1.42
2.3
5.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
14
75
1.95
1.39
2.1
3.8
u/ml
26.1
2090.9
0.55
14
61
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
17
3.00
1.37
1.0
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
22
138
1.69
1.35
4.2
2.2
nmol/l
378.8
374.7
0.05
22
127
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
40
0.00
1.34
0.0
3.0
—
89.1
—
0
21
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
18
2.83
1.29
1.8
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
35
2.35
1.29
4.8
4.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
144
0.46
1.28
1.0
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
27
183
1.57
1.23
1.5
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
19
2.68
1.22
2.0
2.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
14
80
1.82
1.17
5.4
3.0
e6/l
0.3
0.1
0.55
14
80
(3022806) Fractional oxyhemoglobin in Capillary blood
5
21
2.42
1.10
6.2
2.2
%
77.9
91.1
—
5
21
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
32
2.24
1.09
1.3
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
64
525
1.36
1.09
6.5
3.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
33
2.17
1.07
1.3
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
46
2.01
1.05
1.2
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
22
2.31
1.04
15.6
3.7
u/ml
46.2
47.9
—
5
22
(40761511) CBC panel - Blood by Automated count
149
1407
1.64
1.03
30.6
14.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
48
1.92
1.02
1.7
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
49
1.88
1.00
1.6
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
46
364
1.37
0.97
6.2
4.2
estimate
0.0
0.0
0.00
20
126
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
118
1272
0.74
0.90
5.3
6.1
mmol/mol
39.3
40.7
0.97
110
1186
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
42
1.95
0.90
1.6
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
156
1502
1.79
0.88
50.6
22.3
e9/l
6.4
6.6
0.81
150
1463
(3026361) Erythrocytes [#/volume] in Blood
156
1501
1.81
0.88
50.7
22.3
e12/l
4.2
4.5
5.88
150
1462
(3007461) Platelets [#/volume] in Blood
156
1500
1.82
0.87
50.8
22.3
e9/l
242.2
243.3
0.07
150
1465
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
164
1.47
0.86
7.7
8.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
45
1.82
0.85
2.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
78
677
1.29
0.85
5.6
3.8
estimate
0.0
0.0
0.00
21
129
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
122
0.55
0.82
1.1
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
33
1.85
0.80
3.8
4.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
109
995
1.28
0.77
4.2
3.6
pmol/l
14.7
14.8
0.18
99
889
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
24
2.12
0.75
1.2
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
60
1.71
0.74
1.3
2.4
u/l
31.4
44.5
—
10
52
(3012516) Albumin [Mass/volume] in Urine
33
412
0.75
0.73
3.8
3.4
mg/l
6437.9
209.9
1.05
19
272
(3021601) Nitrite [Presence] in Urine by Test strip
78
688
1.26
0.72
7.6
5.1
estimate
0.0
0.0
0.00
21
131
(3041096) Erythrocytes [Presence] in Urine by Automated
45
371
1.29
0.71
5.9
3.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
69
1.64
0.70
2.4
3.5
%
1.1
1.2
0.11
11
69
(3049717) Cytology report of Urine Cyto stain
10
62
1.65
0.66
2.5
2.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
28
1.81
0.66
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
44
1.62
0.66
6.3
4.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
8
49
1.66
0.63
2.0
4.4
mmol/l
4.1
3.9
—
8
44
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
91
827
1.23
0.60
2.7
2.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
53
1.54
0.59
1.5
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
143
1.37
0.55
1.7
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
130
1359
0.79
0.53
4.2
5.1
mmol/l
2.6
2.7
1.09
118
1250
(1761868) Lipid panel - Serum or Plasma
38
448
0.80
0.53
3.2
3.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
38
447
0.80
0.52
2.1
3.2
mmol/l
6.6
7.4
0.40
29
370
(40761536) Microorganisms panel - Urine sediment
16
120
1.37
0.48
6.6
4.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
68
1.50
0.48
2.8
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
83
0.59
0.47
1.0
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
38
441
0.82
0.46
2.9
4.1
mg/mmol
7.3
9.4
0.23
21
282
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
130
0.67
0.45
1.1
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
78
1.44
0.44
4.0
3.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
128
1222
1.22
0.43
34.8
16.3
%
36.1
40.1
4.27
88
869
(3009261) Glucose [Presence] in Urine by Test strip
76
696
1.17
0.42
5.7
3.8
estimate
0.0
0.0
0.00
21
121
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
33
1.53
0.41
1.6
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
33
1.53
0.41
1.6
1.8
—
—
—
0
0
(4062490)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(4146454)
0
16
0.00
0.41
0.0
3.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
16
0.00
0.41
0.0
1.1
—
7.7
—
0
9
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(4010399)
7
101
0.68
0.41
1.1
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
34
292
1.21
0.39
1.6
1.8
pmol/l
442.1
468.0
0.28
26
252
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
111
0.71
0.38
1.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
36
1.40
0.38
1.4
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
41
1.48
0.36
3.2
3.4
kpa
7.5
8.5
—
6
41
(3013290) Carbon dioxide [Partial pressure] in Blood
6
41
1.48
0.36
3.2
3.4
kpa
5.1
5.0
—
6
41
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
42
1.44
0.36
1.5
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
88
0.67
0.34
1.3
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
46
1.32
0.33
2.7
3.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
127
1313
0.85
0.31
4.5
4.7
mmol/l
5.8
6.0
1.43
114
1201
(3048689) Calprotectin [Mass/mass] in Stool
19
157
1.24
0.31
3.4
2.5
ug/g
140.0
150.1
0.07
13
128
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
15
122
1.25
0.28
2.0
2.2
ug/l
5.7
8.0
0.33
15
108
(40761535) Cells panel - Urine sediment
13
104
1.27
0.27
5.0
3.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
303
1.15
0.26
1.2
1.2
u/ml
2.1
1.1
0.44
13
81
(3019150) Specific gravity of Urine by Refractometry
33
294
1.15
0.26
6.8
4.1
kg/l
1.0
1.0
—
7
34
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
129
1324
0.88
0.23
3.8
4.6
mmol/l
1.4
1.4
1.26
117
1215
(3019832) Treponema pallidum Ab [Presence] in Serum
13
107
1.23
0.22
1.4
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
130
1332
0.88
0.21
3.8
4.6
mmol/l
4.4
4.6
0.91
119
1232
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
13.2
—
0
12
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
58
546
1.10
0.19
4.2
5.1
ug/l
2.7
2.8
0.04
53
485
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
30
273
1.12
0.17
4.0
3.6
ng/l
32.0
213.0
2.02
22
216
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
127
1246
1.09
0.13
5.1
4.3
mu/l
1.9
1.9
0.00
117
1126
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
46
1.09
0.09
1.4
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
47
1.07
0.09
1.2
1.4
—
2.7
—
0
7
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
21
224
0.93
0.07
1.1
1.3
iu/ml
14.0
33.8
—
5
67
(40768797) Stomach Pathology biopsy report
20
187
1.08
0.07
1.6
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
93
913
1.04
0.06
3.2
3.3
u/l
60.4
54.3
0.22
88
846
(3011397) Hemoglobin [Presence] in Urine by Test strip
34
327
1.05
0.05
4.8
3.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
129
1278
1.04
0.04
3.5
4.1
mmol/l
1.2
1.3
0.53
120
1169
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
212
1.04
0.02
1.2
1.3
u/ml
30.4
5.5
—
5
85
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
12
113
1.07
0.02
1.2
2.8
ng/l
155.8
191.6
0.19
12
98
(36660697) Celiac disease serology panel - Serum
11
104
1.06
0.01
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
12
126
0.95
0.00
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
16
154
1.04
0.00
1.6
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
18
174
1.04
0.00
1.3
1.4
titre
224.0
447.6
—
5
42
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
32
314
1.02
0.00
2.5
3.0
ug/l
0.8
0.8
0.01
22
218
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
14
144
0.97
0.00
2.1
2.3
u/l
43.0
34.9
—
9
120
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
43
434
0.99
0.00
3.9
4.3
%
21.4
21.6
0.02
19
225
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
23
227
1.02
0.00
1.3
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
105
1.05
0.00
7.9
2.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
55.7
—
0
6
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
28.2
—
0
6
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
7.7
—
0
6
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
0.9
—
0
8
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
2.3
—
13.4
—
0
8
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(1002224) Polysomnography panel
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
155.4
—
0
5
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.3
—
0.6
—
0
7
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
10.9
—
1447.9
—
0
9
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.1
—
6.3
—
0
8
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.3
—
983.6
—
0
9
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(3010375) cycloSPORINE [Mass/volume] in Blood
0
8
0.00
0.00
0.0
37.9
—
116.6
—
0
8
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BONE_CARTILAGE_NAS – Malignant neoplasm of bone and articular cartilage of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).